Systemic sclerosis causes 1 in 2 deaths within 4 years of diagnosis

23-05-2025

A S$6 million grant at the Singapore General Hospital will fund a new project for systemic sclerosis patients. The aim is to better diagnosis and personalised treatment for the disease that has poor survival rates, killing one in two Asian patients within four years of diagnosis. Researchers will analyse patients' genes, immune systems, gut bacteria and more over the next five years. Associate Professor Andrea Low, Lead of the Singapore Systemic Sclerosis Precision Medicine Project and Senior Consultant at SGH, explains why Asian patients have poor survival rates with this disease and the factors contributing to it. She also points out how the Singapore Systemic Sclerosis Precision Medicine Project differs from existing programmes treating this disease.

Hashtags

Health

Science

#systemicsclerosis

#personalisedmedicine

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

New virtual reality tool screens signs of pre-dementia with up to 90% accuracy

CNA

2 hours ago

New virtual reality tool screens signs of pre-dementia with up to 90% accuracy

A new virtual reality tool will detect signs of pre-dementia in seniors with up to 90 per cent accuracy. This will cut screening times from hours to around 15 minutes. Amid rising cases of dementia in Singapore, only one in eight people who has pre-dementia is diagnosed with it during primary-care visits. Clinical Associate Professor Tan Ngiap Chuan from SingHealth Polyclinics shares more on the findings and uses of the VR dementia tool CAVIRE-2 in a study detecting signs of pre-dementia in seniors.

Taiwan hopes to attract young blood to its chip industry

CNA

3 hours ago

Taiwan hopes to attract young blood to its chip industry

Starting them young on semiconductors, Taiwan is finding novel ways for students to spend their summers, clad in white lab coats, masks and learning how to make microchips.

Digital health company eMed taps former X CEO Linda Yaccarino

CNA

4 hours ago

Digital health company eMed taps former X CEO Linda Yaccarino

Digital health platform eMed Population Health said on Tuesday it has appointed Linda Yaccarino, the former CEO of social media site X, as its chief executive officer. The online weight management company's digital platform provides at-home diagnostics, proctor-led screenings, physician-guided prescribing for patients with obesity and type 2 diabetes. Yaccarino, one of Elon Musk's top deputies, stepped down from her role at the social media site in July, in a surprise move just months after the platform was acquired by the billionaire's AI startup, xAI.